CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 79337-79613 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T651","span":{"begin":0,"end":276},"obj":"Sentence"},{"id":"T73643","span":{"begin":0,"end":276},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Moreover, in experimental animal models of MRSA endocarditis and cefalosporin-resistant pneumococcal meningitis, fosfomycin and b-lactam (or vancomycin) combinations have proved to be superior than monotherapies, preventing the emergence of drug-resistant populations as well."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T209","span":{"begin":0,"end":276},"obj":"Sentence"}],"text":"Moreover, in experimental animal models of MRSA endocarditis and cefalosporin-resistant pneumococcal meningitis, fosfomycin and b-lactam (or vancomycin) combinations have proved to be superior than monotherapies, preventing the emergence of drug-resistant populations as well."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T61","span":{"begin":48,"end":60},"obj":"Phenotype"},{"id":"T62","span":{"begin":101,"end":111},"obj":"Phenotype"}],"attributes":[{"id":"A61","pred":"hp_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/HP_0100584"},{"id":"A62","pred":"hp_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/HP_0001287"}],"text":"Moreover, in experimental animal models of MRSA endocarditis and cefalosporin-resistant pneumococcal meningitis, fosfomycin and b-lactam (or vancomycin) combinations have proved to be superior than monotherapies, preventing the emergence of drug-resistant populations as well."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T263","span":{"begin":43,"end":47},"obj":"Disease"},{"id":"T264","span":{"begin":48,"end":60},"obj":"Disease"},{"id":"T265","span":{"begin":88,"end":111},"obj":"Disease"},{"id":"T266","span":{"begin":101,"end":111},"obj":"Disease"},{"id":"T41685","span":{"begin":43,"end":47},"obj":"Disease"},{"id":"T35129","span":{"begin":48,"end":60},"obj":"Disease"},{"id":"T40875","span":{"begin":88,"end":111},"obj":"Disease"},{"id":"T19285","span":{"begin":101,"end":111},"obj":"Disease"}],"attributes":[{"id":"A263","pred":"mondo_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A264","pred":"mondo_id","subj":"T264","obj":"http://purl.obolibrary.org/obo/MONDO_0005025"},{"id":"A265","pred":"mondo_id","subj":"T265","obj":"http://purl.obolibrary.org/obo/MONDO_0006913"},{"id":"A266","pred":"mondo_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/MONDO_0004796"},{"id":"A267","pred":"mondo_id","subj":"T266","obj":"http://purl.obolibrary.org/obo/MONDO_0021108"},{"id":"A25872","pred":"mondo_id","subj":"T41685","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A18594","pred":"mondo_id","subj":"T35129","obj":"http://purl.obolibrary.org/obo/MONDO_0005025"},{"id":"A55196","pred":"mondo_id","subj":"T40875","obj":"http://purl.obolibrary.org/obo/MONDO_0006913"},{"id":"A71356","pred":"mondo_id","subj":"T19285","obj":"http://purl.obolibrary.org/obo/MONDO_0004796"},{"id":"A62086","pred":"mondo_id","subj":"T19285","obj":"http://purl.obolibrary.org/obo/MONDO_0021108"}],"text":"Moreover, in experimental animal models of MRSA endocarditis and cefalosporin-resistant pneumococcal meningitis, fosfomycin and b-lactam (or vancomycin) combinations have proved to be superior than monotherapies, preventing the emergence of drug-resistant populations as well."}